ZA98367B - Antibodies which bind to the nidogen-binding domain of laminin their preparation and use - Google Patents

Antibodies which bind to the nidogen-binding domain of laminin their preparation and use

Info

Publication number
ZA98367B
ZA98367B ZA98367A ZA98367A ZA98367B ZA 98367 B ZA98367 B ZA 98367B ZA 98367 A ZA98367 A ZA 98367A ZA 98367 A ZA98367 A ZA 98367A ZA 98367 B ZA98367 B ZA 98367B
Authority
ZA
South Africa
Prior art keywords
nidogen
laminin
antibodies
bind
preparation
Prior art date
Application number
ZA98367A
Other languages
English (en)
Inventor
Martin Gerl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA98367B publication Critical patent/ZA98367B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA98367A 1997-01-17 1998-01-16 Antibodies which bind to the nidogen-binding domain of laminin their preparation and use ZA98367B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19701607A DE19701607A1 (de) 1997-01-17 1997-01-17 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ZA98367B true ZA98367B (en) 1998-07-17

Family

ID=7817701

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98367A ZA98367B (en) 1997-01-17 1998-01-16 Antibodies which bind to the nidogen-binding domain of laminin their preparation and use

Country Status (18)

Country Link
US (1) US20010007020A1 (de)
EP (1) EP0954535A1 (de)
JP (1) JP2001509020A (de)
KR (1) KR20000070256A (de)
CN (1) CN1244873A (de)
AR (1) AR011074A1 (de)
AU (1) AU5985398A (de)
BR (1) BR9714207A (de)
CA (1) CA2278477A1 (de)
CZ (1) CZ253899A3 (de)
DE (1) DE19701607A1 (de)
HU (1) HUP0001808A3 (de)
ID (1) ID21895A (de)
IL (1) IL130808A0 (de)
PL (1) PL334956A1 (de)
TR (1) TR199901648T2 (de)
WO (1) WO1998031709A1 (de)
ZA (1) ZA98367B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087318A1 (en) * 1994-04-18 2003-05-08 Lallone Roger L. Antibodies against an extracellular matrix complex and their use in the detection of cancer
EP1070727A1 (de) 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Niedermolekulare Peptide als Inhibitoren der Laminin/Nidogen Wechselwirkung
AU784338B2 (en) * 1999-11-01 2006-03-16 Curagen Corporation Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
WO2001061349A1 (en) * 2000-02-18 2001-08-23 The University Of Tennessee Research Corporation Detection of microbial deposition and immune response at the basement membrane
EP1268783B9 (de) * 2000-03-29 2007-01-17 Beth Israel Deaconess Medical Center, Inc. Anti-angiogenic properties of matin and of fragments or variants thereof
US20030119739A1 (en) * 2000-03-29 2003-06-26 Beth Israel Deaconess Medical Center Anti-angiogenic and anti-tumor properties of Vascostatin and other nidogen domains
WO2004093892A2 (en) 2003-04-16 2004-11-04 Genentech, Inc. Stanniocalcin-1, variant or antagonists thereof for selective modulation of vascularization
US20140045196A1 (en) * 2012-08-13 2014-02-13 University Of Tokyo Methods of prognosis and diagnosis of cancer
CN110860766A (zh) * 2019-10-22 2020-03-06 广东开放大学（广东理工职业学院） 铝合金薄板的调制脉冲电流焊接方法、系统及存储介质

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211657A (en) * 1988-11-07 1993-05-18 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
DE59511090D1 (de) * 1994-08-11 2008-05-08 Sanofi Aventis Deutschland Monoklonale Antikörper zur selektiven immunologischen Bestimmung von hochmolekularen, intakten Lamininformen in Körperflüssigkeiten
US5493008A (en) * 1994-08-15 1996-02-20 The University Of Virginia Patent Foundation Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain

Also Published As

Publication number Publication date
HUP0001808A2 (hu) 2000-09-28
CZ253899A3 (cs) 1999-10-13
AU5985398A (en) 1998-08-07
DE19701607A1 (de) 1998-07-23
KR20000070256A (ko) 2000-11-25
CA2278477A1 (en) 1998-07-23
US20010007020A1 (en) 2001-07-05
AR011074A1 (es) 2000-08-02
BR9714207A (pt) 2000-03-28
JP2001509020A (ja) 2001-07-10
CN1244873A (zh) 2000-02-16
HUP0001808A3 (en) 2001-09-28
PL334956A1 (en) 2000-03-27
IL130808A0 (en) 2001-01-28
EP0954535A1 (de) 1999-11-10
ID21895A (id) 1999-08-05
TR199901648T2 (xx) 1999-10-21
WO1998031709A1 (de) 1998-07-23

Similar Documents

Publication Publication Date Title
HUP1500179A2 (en) The use of human tnf-alpha binding antibodies
IL144578A0 (en) Antibodies specific to kdr and uses thereof
ID26590A (id) Komposisi-komposisi dua fasa bebas pewangi dan metode-metode untuk menurunkan bau badan dan lingkungan
FI963126L (fi) Stanoliseos ja sen käyttö
IL112529A0 (en) Peptides and compounds that bind to the IL-1 receptor
PL330111A1 (en) Concentyratyed antibody preparation
EP1032421A4 (de) Natürliche menschliche monoklonale antikörper
IL136113A0 (en) Modified antibodies with enhanced ability to elicit an anti-idiotype response
AU4972096A (en) Peptides and compounds that bind to sh2 domains
HUP0400697A3 (en) Silensed anti-cd28 antibodies and use thereof
AU6949800A (en) Compositions and methods for the treatment of sepsis using antibodies to c5a
GB2327190B (en) Process for the preparation of depilatory compositions and their use
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
HUP0101151A3 (en) Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbetha6-integrin attachment to fibnronectin
EG21286A (en) Blends of organosillane compounds and their use
ZA98367B (en) Antibodies which bind to the nidogen-binding domain of laminin their preparation and use
ZA985457B (en) Isolated nona- and decapeptides which bind to HLA molecules and the use thereof
FI964854A7 (fi) Hydroksitioasetamidien valmistus ja niiden käyttö bentsotiofeenien syn teesissä
EP0934063A4 (de) Verwendung von hyalorunan in gentherapie
EP1070081A4 (de) Neue moleküle der t129-ähnlichen proteinfamilie und ihre anwendung
GB9723062D0 (en) Improvements relating to antibodies and libraries thereof
GB9706010D0 (en) Determination of antibody-antigen binding and clinical products
GB9828185D0 (en) Preparation of antibodies
GB9516606D0 (en) Antibodies their preparation and use
GB2371049B (en) Methods of making antibodies against ß-forms of prion proteins and their uses